Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Interest & Investment Income (2023 - 2025)

Immunocore Holdings' Interest & Investment Income history spans 3 years, with the latest figure at $3.9 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 24.49% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $16.5 million, down 35.69%, while the annual FY2025 figure was $16.5 million, 35.69% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $3.9 million at Immunocore Holdings, down from $4.1 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $8.2 million in Q1 2024 and bottomed at $3.1 million in Q1 2023.
  • The 3-year median for Interest & Investment Income is $4.7 million (2023), against an average of $5.0 million.
  • The largest annual shift saw Interest & Investment Income surged 163.62% in 2024 before it crashed 49.36% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $5.4 million in 2023, then fell by 4.91% to $5.2 million in 2024, then fell by 24.49% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Interest & Investment Income are $3.9 million (Q4 2025), $4.1 million (Q3 2025), and $4.3 million (Q2 2025).